These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8382649)

  • 21. Core imprint cytology of screen-detected breast lesions is predictive of the histologic results.
    Farshid G; Pieterse S
    Cancer; 2006 Jun; 108(3):150-6. PubMed ID: 16634070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thermobiologic evaluation of benign and malignant breast diseases].
    Gautherie M; Haehnel P; Walter JP
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):22-8. PubMed ID: 2984083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
    Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
    Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA.
    Schedel H; Oellinger H; Kohlschein P; Siewert C; Hadijuana J; Blohmer JU; Kissner T; Felix R
    Zentralbl Gynakol; 2002 Feb; 124(2):104-10. PubMed ID: 11935495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy.
    Preda L; Villa G; Rizzo S; Bazzi L; Origgi D; Cassano E; Bellomi M
    Breast Cancer Res; 2006; 8(5):R53. PubMed ID: 16959028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnosis of breast lesions 5 mm or less: is there a role for magnetic resonance imaging?
    Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
    J Comput Assist Tomogr; 2010; 34(3):456-64. PubMed ID: 20498554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ultrasonic mammography: its importance in integrated diagnosis of breast diseases (author's transl)].
    Thiel C; Schweikhart G
    Rofo; 1982 Jul; 137(1):1-12. PubMed ID: 6286434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Typical and unusual findings in MR mammography].
    Bick U
    Rofo; 2000 May; 172(5):415-28. PubMed ID: 10874968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of high-resolution real-time sonography in breast cancer].
    Leucht W; Rabe D; Boos R; Humbert KD; von Fournier D; Schmidt W
    Geburtshilfe Frauenheilkd; 1984 Sep; 44(9):557-62. PubMed ID: 6092202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Signal characteristics of malignant and benign lesions in dynamic 2D-MRT of the breast].
    Fischer U; von Heyden D; Vosshenrich R; Vieweg I; Grabbe E
    Rofo; 1993 Apr; 158(4):287-92. PubMed ID: 8477067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast magnetic resonance imaging: an overview for nonradiologists.
    Margolies L; Ha R
    Mt Sinai J Med; 2009 Dec; 76(6):598-605. PubMed ID: 20014426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging in the diagnosis of breast disease.
    Dash N; Lupetin AR; Daffner RH; Deeb ZL; Sefczek RJ; Schapiro RL
    AJR Am J Roentgenol; 1986 Jan; 146(1):119-25. PubMed ID: 3484399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Doubtful mammographic findings: the value of negative MR mammography for tumor exclusion].
    Rieber A; Merkle E; Zeitler H; Adler S; Kreienberg R; Brambs HJ; Tomczak R
    Rofo; 1997 Oct; 167(4):392-8. PubMed ID: 9417269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nuclear magnetic resonance tomography of the breast: diagnosis, differential diagnosis, problems and possible solutions. II: Diagnosis].
    Kaiser W; Zeitler E
    Rofo; 1986 May; 144(5):572-9. PubMed ID: 3012684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of the breast: potential for lesion characterization.
    Rotaru N; Luciani A
    J BUON; 2004; 9(1):77-82. PubMed ID: 17385833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma].
    Tomczak R; Rieber A; Zeitler H; Rilinger N; Kreienberg R; Brambs HJ
    Rofo; 1996 Aug; 165(2):148-51. PubMed ID: 8924667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of immunohistochemistry on the final diagnosis of breast biopsies.
    Trocchi P; Holzhausen HJ; Böcker W; Schmidt-Pokrzywniak A; Ruschke K; Thomssen C; Löning T; Kluttig A; Stang A
    Histopathology; 2013 Dec; 63(6):817-25. PubMed ID: 24236511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Magnetic resonance imaging in the diagnosis of breast diseases].
    Boné BK; Szabó B; Palkó A; Aspelin P
    Orv Hetil; 2001 Sep; 142(39):2123-31. PubMed ID: 11723831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and radiographic methods in the diagnosis of breast neoplasms].
    Gniewosz Z
    Wiad Lek; 1971 Dec; 24(23):2201-8. PubMed ID: 4334393
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnetic resonance imaging of intraductal papillomas: typical findings and differential diagnosis.
    Dietzel M; Kaiser C; Baltzer PA
    J Comput Assist Tomogr; 2015; 39(2):176-84. PubMed ID: 25423553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.